A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.

ABSTRACT: While the standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses administered 3 weeks apart, some public health authorities are spacing these doses, raising concerns about efficacy. However, data indicate that a single dose can be up to 90% effective starting 14 days post-administration. To assess the mechanisms contributing to protection, we analyzed humoral and T cell responses three weeks after a single BNT162b2 dose. We observed weak neutralizing activity elicited in SARS-CoV-2 naive individuals but strong anti-receptor binding domain and spike antibodies with Fc-mediated effector functions and cellular CD4⁺ T cell responses. In previously infected individuals, a single dose boosted all humoral and T cell responses, with strong correlations between T

SUBMITTER: Tauzin A 

PROVIDER: S-EPMC8175625 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature